• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[黏液黏稠病患者的肺部细菌感染]

[Bacterial infections of the lungs in mucoviscidosis patients].

作者信息

Hogardt M, Heesemann J

机构信息

Max von Pettenkofer-Institut der LMU, München.

出版信息

MMW Fortschr Med. 2005 Jan 27;147(4):38-40.

PMID:15745340
Abstract

The pathogenesis of lung infections in patients with mucoviscidosis (cystic fibrosis, CF) is multifactorial. Both host- and pathogen-related factors are involved. The most important germ in terms of progression and pulmonary damage is Pseudomonas aeruginosa. However, the clinical relevance of other CF-typical pathogens has not yet been determined with certainty, and must be assessed on the basis of the clinical presentation of the individual case. To ensure optimal patient management, a CF-specific microbiological diagnostic work-up is mandatory. Since ever more patients now survive into adulthood, the problems associated with chronic infection are gaining in importance. In light of increasing multiresistance, the use of inhalation antibiotics, as well as combined antibiotic treatment, is becoming more and more determinative for the therapeutic outcome.

摘要

黏液黏稠症(囊性纤维化,CF)患者肺部感染的发病机制是多因素的。宿主相关因素和病原体相关因素均有涉及。就病情进展和肺部损伤而言,最重要的病原体是铜绿假单胞菌。然而,其他CF典型病原体的临床相关性尚未明确确定,必须根据个别病例的临床表现进行评估。为确保对患者进行最佳管理,必须进行CF特异性微生物学诊断检查。由于现在越来越多的患者存活至成年,与慢性感染相关的问题日益重要。鉴于多重耐药性不断增加,吸入性抗生素的使用以及联合抗生素治疗对治疗结果越来越具有决定性作用。

相似文献

1
[Bacterial infections of the lungs in mucoviscidosis patients].[黏液黏稠病患者的肺部细菌感染]
MMW Fortschr Med. 2005 Jan 27;147(4):38-40.
2
Antibiotic use in cystic fibrosis.囊性纤维化中的抗生素使用。
Curr Opin Pulm Med. 1996 Nov;2(6):439-46.
3
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.囊性纤维化患者间歇性铜绿假单胞菌气道定植的早期积极根除治疗:15年经验
J Cyst Fibros. 2008 Nov;7(6):523-30. doi: 10.1016/j.jcf.2008.06.009. Epub 2008 Aug 9.
4
Update on antibiotics for infection control in cystic fibrosis.囊性纤维化感染控制抗生素的更新。
Expert Rev Anti Infect Ther. 2009 Oct;7(8):967-80. doi: 10.1586/eri.09.82.
5
The approach to Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化中铜绿假单胞菌的治疗方法。
Semin Respir Crit Care Med. 2009 Oct;30(5):587-95. doi: 10.1055/s-0029-1238917. Epub 2009 Sep 16.
6
Value of inhaled antibiotics in cystic fibrosis patients.吸入性抗生素在囊性纤维化患者中的价值。
Acta Univ Carol Med (Praha). 1990;36(1-4):34-6.
7
[How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].[在囊性纤维化病程中,慢性铜绿假单胞菌支气管感染应如何治疗?]
Rev Mal Respir. 2003 Apr;20(2 Pt 2):S129-35.
8
Cystic fibrosis infections: treatment strategies and prospects.囊性纤维化感染:治疗策略与前景
FEMS Microbiol Lett. 2009 Nov;300(2):153-64. doi: 10.1111/j.1574-6968.2009.01704.x. Epub 2009 Aug 4.
9
Pulmonary infection in mild variant cystic fibrosis: implications for care.轻度变异型囊性纤维化中的肺部感染:对护理的影响
J Cyst Fibros. 2006 May;5(2):101-4. doi: 10.1016/j.jcf.2005.11.005. Epub 2006 Jan 19.
10
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.丹麦、挪威和瑞典囊性纤维化中心铜绿假单胞菌的患病率及治疗差异。
J Cyst Fibros. 2009 Mar;8(2):135-42. doi: 10.1016/j.jcf.2008.11.001. Epub 2009 Jan 20.